Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus
Authors:
Open Access
- 6 March 2025
- journal article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 72, 152669
Abstract
No abstract availableKeywords
Funding Information
- Arthritis New Zealand
This publication has 11 references indexed in Scilit:
- ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified DelphiPLOS Medicine, 2024
- The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition diseaseAnnals of the Rheumatic Diseases, 2023
- Diagnosis and Treatment of Calcium Pyrophosphate Deposition (CPPD) Disease: A ReviewOpen Access Rheumatology: Research and Reviews, 2023
- Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working groupSeminars in Arthritis and Rheumatism, 2021
- Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working groupSeminars in Arthritis and Rheumatism, 2021
- Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working groupSeminars in Arthritis and Rheumatism, 2020
- OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention StudiesThe Journal of Rheumatology, 2019
- Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT MethodologyThe Journal of Rheumatology, 2019
- Non-response in surveys of very old peopleEuropean Journal of Ageing, 2018
- European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosisAnnals of the Rheumatic Diseases, 2011